North East England, United Kingdom
£49,101,271
February 20, 2026 at 17:00
Other
006436-2026
For detailed contact information, please refer to the official procurement documents.
Sign up to view complete requirements and analysis
No credit card required • Setup in 2 minutes
Sign up to view document summaries and analysis
No credit card required • Setup in 2 minutes
This tender presents a clear scope for critical pharmaceutical logistics services but suffers from significant gaps in transparency regarding evaluation criteria and detailed financial requirements, raising fairness concerns.
The tender defines an Open procedure with a reasonable submission period from today's date and correctly assigns the CPV code. There are no reported disputes or suspensions. However, the reveal date is missing, and mandatory exclusion grounds are not explicitly detailed in the provided summaries, which are minor points.
The service description is clear and unambiguous, outlining the scope and scale of the required pharmaceutical logistics. However, a critical deficiency is the explicit absence of specified evaluation criteria, making it difficult for bidders to understand how their proposals will be judged. Detailed financial requirements for bidders are also not provided in the summary.
Basic information such as title, reference, organization, estimated value, duration, and location (NUTS code) is well-provided. However, the tender is incomplete due to the absence of evaluation criteria and detailed financial requirements for bidders. Additionally, one of the listed tender documents failed to provide a summary, indicating a potential access or processing issue.
Fairness is significantly compromised by the complete absence of evaluation criteria, preventing objective and transparent assessment of bids. The requirement for a 'single lead provider' for such a large and complex service inherently limits competition. Furthermore, the technical capability requirement to 'ideally building on experience developed through programmes like the COVID‑19 vaccination programme' could be perceived as tailoring the tender towards an incumbent or a very limited number of large, established providers, thereby reducing equal access for other qualified entities.
The tender supports electronic submission via the Health Family Single eCommercial System, which enhances practicality. Key dates like contract start and duration are clearly specified. However, a direct document URL is not provided in the summary, and detailed financial requirements for bidders are not explicitly available, which could pose minor practical hurdles.
The tender data is largely consistent, with logical dates and no reported disputes or suspensions. Most key fields are populated. Minor inconsistencies include missing codes for the 'Type' and 'Procedure' fields, and the 'Liable Person' field being empty. The automated check's 'No e-submission' flag contradicts the explicit text in the AI-extracted requirements and document summaries, which clearly state e-submission is mandatory.
The tender positively includes a requirement for bidders to address the contracting authority's commitment to social value, indicating an awareness of social aspects in procurement. However, there is no explicit mention of green procurement initiatives or a focus on innovation, limiting its overall sustainability score.
Sign up to view complete requirements and analysis
No credit card required • Setup in 2 minutes
Ask me anything about this tender
Hello! I'm your AI assistant for this tender. I can help you understand requirements, deadlines, eligibility criteria, and provide strategic insights.
No credit card required
Setup in 2 minutes